Log in

Relevant bibliographies by topics / Antibacterial prophylaxis / Journal articles

To see the other types of publications on this topic, follow the link: Antibacterial prophylaxis.

Journal articles on the topic 'Antibacterial prophylaxis'

Author: Grafiati

Published: 28 May 2022

Last updated: 31 July 2025

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Antibacterial prophylaxis.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Hall, Ellis H., Robert G. Sherman, Wesley W. Emmons, and Gregory D. Naylor. "ANTIBACTERIAL PROPHYLAXIS." Dental Clinics of North America 38, no. 4 (1994): 707–18. http://dx.doi.org/10.1016/s0011-8532(22)00185-9.

Full text

APA, Harvard, Vancouver, ISO, and other styles

2

Cruciani, Mario. "Antibacterial prophylaxis." International Journal of Antimicrobial Agents 16, no. 2 (2000): 123–25. http://dx.doi.org/10.1016/s0924-8579(00)00216-8.

Full text

APA, Harvard, Vancouver, ISO, and other styles

3

&NA;. "Amending antibacterial prophylaxis." Inpharma Weekly &NA;, no. 840 (1992): 18. http://dx.doi.org/10.2165/00128413-199208400-00030.

Full text

APA, Harvard, Vancouver, ISO, and other styles

4

NOAMAN, AYAD THABT. "Prophylaxis Antibacterial for Leukemia of Pediatrics Patient." Journal of Research on the Lepidoptera 50, no. 4 (2019): 9–16. http://dx.doi.org/10.36872/lepi/v50i4/201058.

Full text

APA, Harvard, Vancouver, ISO, and other styles

5

&NA;. "Perioperative antibacterial prophylaxis examined." Inpharma Weekly &NA;, no. 1201 (1999): 4. http://dx.doi.org/10.2165/00128413-199912010-00004.

Full text

APA, Harvard, Vancouver, ISO, and other styles

6

&NA;. "Antibacterial prophylaxis in surgery." Inpharma Weekly &NA;, no. 824 (1992): 12–13. http://dx.doi.org/10.2165/00128413-199208240-00026.

Full text

APA, Harvard, Vancouver, ISO, and other styles

7

&NA;. "Perioperative antibacterial prophylaxis inadequate." Inpharma Weekly &NA;, no. 829 (1992): 17. http://dx.doi.org/10.2165/00128413-199208290-00033.

Full text

APA, Harvard, Vancouver, ISO, and other styles

8

Kleinberg, Michael. "Counterpoint: Routine Anti-Bacterial Prophylaxis Is Not Indicated in Neutropenic Patients With Hematological Malignancies." Journal of the National Comprehensive Cancer Network 2, no. 5 (2004): 445–51. http://dx.doi.org/10.6004/jnccn.2004.0035.

Full text

Abstract:

Preventing bacterial infections by prescribing prophylactic antibiotics is seen by many as an important strategy for decreasing infectious mortality in the most profoundly immunosuppressed patients with hematologic malignancies. Comparative studies show consistently that neutropenic patients treated with prophylactic fluoroquinolone antibiotics develop fewer bacteremias than patients treated with placebo or less-potent antibacterials. However, these same studies fail to show increased survival rates in fluoroquinolone-treated patients. This repeated observation is the basis for the continued c

APA, Harvard, Vancouver, ISO, and other styles

9

Bohnen, John. "Principles of Perioperative Antibacterial Prophylaxis." Disease Management and Health Outcomes 6, no. 2 (1999): 73–81. http://dx.doi.org/10.2165/00115677-199906020-00003.

Full text

APA, Harvard, Vancouver, ISO, and other styles

10

&NA;. "Antibacterial prophylaxis for streptococcal infection?" Inpharma Weekly &NA;, no. 1081 (1997): 17. http://dx.doi.org/10.2165/00128413-199710810-00037.

Full text

APA, Harvard, Vancouver, ISO, and other styles

11

Rosengren, Helena, and Anthony Dixon. "Antibacterial Prophylaxis in Dermatologic Surgery." American Journal of Clinical Dermatology 11, no. 1 (2010): 35–44. http://dx.doi.org/10.2165/11311090-000000000-00000.

Full text

APA, Harvard, Vancouver, ISO, and other styles

12

Reeves, D. S., and D. A. Lewis. "Pharmacokinetic aspects of antibacterial prophylaxis." Journal of Antimicrobial Chemotherapy 31, suppl B (1993): 11–21. http://dx.doi.org/10.1093/jac/31.suppl_b.11.

Full text

APA, Harvard, Vancouver, ISO, and other styles

13

Viscoli, Claudio. "Antibacterial prophylaxis in neutropenic patients." International Journal of Antimicrobial Agents 30 (November 2007): 60–65. http://dx.doi.org/10.1016/j.ijantimicag.2007.06.016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

14

Lehrnbecher, Thomas, Brian T. Fisher, Bob Phillips, et al. "Guideline for Antibacterial Prophylaxis Administration in Pediatric Cancer and Hematopoietic Stem Cell Transplantation." Clinical Infectious Diseases 71, no. 1 (2019): 226–36. http://dx.doi.org/10.1093/cid/ciz1082.

Full text

Abstract:

Abstract Background Bacteremia and other invasive bacterial infections are common among children with cancer receiving intensive chemotherapy and in pediatric recipients of hematopoietic stem cell transplantation (HSCT). Systemic antibacterial prophylaxis is one approach that can be used to reduce the risk of these infections. Our purpose was to develop a clinical practice guideline (CPG) for systemic antibacterial prophylaxis administration in pediatric patients with cancer and those undergoing HSCT. Methods An international and multidisciplinary panel was convened with representation from pe

APA, Harvard, Vancouver, ISO, and other styles

15

Brandwein, Joseph, Elena Liew, David Page, and Peng Wang. "Infectious Complications and Antibiotic Prophylaxis during Induction Therapy with Venetoclax Plus Azacitidine for Previously Untreated AML: A Real-World Experience." Blood 144, Supplement 1 (2024): 5971. https://doi.org/10.1182/blood-2024-199315.

Full text

Abstract:

Venetoclax + azacitidine (ven-aza) induction therapy has become the standard of care at many centers for AML patients who are unfit for intensive induction therapy. Although widely utilized, the efficacy of antimicrobial prophylaxis during induction with this regimen has not been clearly determined. We retrospectively evaluated infectious complications during ven-aza induction therapy in all previously untreated AML patients receiving this regimen at the University of Alberta Hospital, Alberta, Canada from August 2020 - June 2024. There were 93 patients; the median age was 76 (range 58-90) yea

APA, Harvard, Vancouver, ISO, and other styles

16

Segal, Brahm H., and Alison G. Freifeld. "Antibacterial Prophylaxis in Patients with Neutropenia." Journal of the National Comprehensive Cancer Network 5, no. 2 (2007): 235–42. http://dx.doi.org/10.6004/jnccn.2007.0023.

Full text

Abstract:

Patients with cancer and chemotherapy-induced neutropenia are at risk for severe bacterial infections. This risk is not uniform among all cancer patients but is dependent primarily on the depth and duration of neutropenia and the type of underlying disease. Accordingly, the decision whether to use antibacterial prophylaxis to prevent serious infections in these patients requires a balance between expected benefit and the risks for infection, adverse drug-related events, and emergence of antibiotic resistance. Although antibacterial prophylaxis has the potential to benefit all patients with che

APA, Harvard, Vancouver, ISO, and other styles

17

&NA;. "Antibacterial prophylaxis recommended in severe pancreatitis." Inpharma Weekly &NA;, no. 1094 (1997): 18. http://dx.doi.org/10.2165/00128413-199710940-00035.

Full text

APA, Harvard, Vancouver, ISO, and other styles

18

&NA;. "Antibacterial prophylaxis in bacterial peritonitis worthwhile." Inpharma Weekly &NA;, no. 1112 (1997): 7. http://dx.doi.org/10.2165/00128413-199711120-00010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

19

&NA;. "Antibacterial prophylaxis in critically ill patients." Inpharma Weekly &NA;, no. 1135 (1998): 16. http://dx.doi.org/10.2165/00128413-199811350-00028.

Full text

APA, Harvard, Vancouver, ISO, and other styles

20

&NA;. "Antibacterial prophylaxis justified during breast surgery." Inpharma Weekly &NA;, no. 880 (1993): 15. http://dx.doi.org/10.2165/00128413-199308800-00034.

Full text

APA, Harvard, Vancouver, ISO, and other styles

21

Amin, Mohammad. "Antibacterial prophylaxis in urology: A review." American Journal of Medicine 92, no. 4 (1992): S114—S117. http://dx.doi.org/10.1016/0002-9343(92)90321-2.

Full text

APA, Harvard, Vancouver, ISO, and other styles

22

GIALDRONIGRASSI, G. "Role and limits of antibacterial prophylaxis." Pharmacological Research 26 (September 1992): 297. http://dx.doi.org/10.1016/1043-6618(92)91303-x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

23

Classen, Annika Y., Larissa Henze, Marie von Lilienfeld-Toal, et al. "Primary prophylaxis of bacterial infections and Pneumocystis jirovecii pneumonia in patients with hematologic malignancies and solid tumors: 2020 updated guidelines of the Infectious Diseases Working Party of the German Society of Hematology and Medical Oncology (AGIHO/DGHO)." Annals of Hematology 100, no. 6 (2021): 1603–20. http://dx.doi.org/10.1007/s00277-021-04452-9.

Full text

Abstract:

AbstractHematologic and oncologic patients with chemo- or immunotherapy-related immunosuppression are at substantial risk for bacterial infections and Pneumocystis jirovecii pneumonia (PcP). As bacterial resistances are increasing worldwide and new research reshapes our understanding of the interactions between the human host and bacterial commensals, administration of antibacterial prophylaxis has become a matter of discussion. This guideline constitutes an update of the 2013 published guideline of the Infectious Diseases Working Party (AGIHO) of the German Society for Hematology and Medical

APA, Harvard, Vancouver, ISO, and other styles

24

Jaiswal, Sanjay, Sharan Shyam, and Vikas Yadav. "A Study on Appropriateness of Antibacterial Use in Acute Wards of a Teaching Hospital." Journal of Drug Delivery and Therapeutics 10, no. 1-s (2020): 144–48. http://dx.doi.org/10.22270/jddt.v10i1-s.3927.

Full text

Abstract:

Objective: A study to analyse the appropriateness of use of antibacterials in acute wards of a tertiary care hospital. Design: A pharmacoepidemiological research study. Intervention: Non-interventional descriptive study. Main Outcome Measure: The antibacterial prescriptions were analyzed for their adherence to or deviation from the standard national treatment guidelines. Results: There were a total of 207 patients comprising of 35 in acute medical ward, 65 in ICU, 53 in acute surgical ward and 54 in family ward, who were prescribed antibacterials. These consisted of a total of 383 prescription

APA, Harvard, Vancouver, ISO, and other styles

25

&NA;. "Antibacterial prophylaxis prevents rebleeding in variceal haemorrhage." Inpharma Weekly &NA;, no. 1434 (2004): 14. http://dx.doi.org/10.2165/00128413-200414340-00040.

Full text

APA, Harvard, Vancouver, ISO, and other styles

26

&NA;. "Cost of perioperative antibacterial prophylaxis in Belgium." Inpharma Weekly &NA;, no. 1131 (1998): 6. http://dx.doi.org/10.2165/00128413-199811310-00010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

27

&NA;. "Dextranomer + hyaluronan vs antibacterial prophylaxis in VUR." Inpharma Weekly &NA;, no. 1334 (2002): 17. http://dx.doi.org/10.2165/00128413-200213340-00035.

Full text

APA, Harvard, Vancouver, ISO, and other styles

28

&NA;. "Antibacterial prophylaxis 'a costsaving strategy' for cholangitis." Inpharma Weekly &NA;, no. 1338 (2002): 7. http://dx.doi.org/10.2165/00128413-200213380-00013.

Full text

APA, Harvard, Vancouver, ISO, and other styles

29

&NA;. "Antibacterial prophylaxis reduces mortality in necrotising pancreatitis." Inpharma Weekly &NA;, no. 1004 (1995): 16. http://dx.doi.org/10.2165/00128413-199510040-00034.

Full text

APA, Harvard, Vancouver, ISO, and other styles

30

&NA;. "Antibacterial prophylaxis in skin surgery is effective ???" Inpharma Weekly &NA;, no. 809 (1991): 16. http://dx.doi.org/10.2165/00128413-199108090-00045.

Full text

APA, Harvard, Vancouver, ISO, and other styles

31

&NA;. "Antibacterial prophylaxis for dental treatment - controversy continues." Inpharma Weekly &NA;, no. 834 (1992): 16. http://dx.doi.org/10.2165/00128413-199208340-00033.

Full text

APA, Harvard, Vancouver, ISO, and other styles

32

Chung, Doo Yong, and Joo Yong Lee. "Recommendations for Antibacterial Prophylaxis in Endourological Procedures." Urogenital Tract Infection 14, no. 1 (2019): 1. http://dx.doi.org/10.14777/uti.2019.14.1.1.

Full text

APA, Harvard, Vancouver, ISO, and other styles

33

Al Omar, Suha, Deema Moumani, and Rawad Rihani. "Antibacterial prophylaxis in pediatric patients with leukemia." Saudi Pharmaceutical Journal 26, no. 6 (2018): 810–16. http://dx.doi.org/10.1016/j.jsps.2018.04.002.

Full text

APA, Harvard, Vancouver, ISO, and other styles

34

Trümpler, U., P. W. Straub, and A. Rosenmund. "Antibacterial prophylaxis with lactoferrin in neutropenic patients." European Journal of Clinical Microbiology & Infectious Diseases 8, no. 4 (1989): 310–13. http://dx.doi.org/10.1007/bf01963459.

Full text

APA, Harvard, Vancouver, ISO, and other styles

35

Volenko, A. V., S. I. Belykh, E. V. Firsova, and Zh N. Kravchuk. "Biocompatible polymer composition for local antibacterial prophylaxis." Biomedical Engineering 28, no. 4 (1994): 217–20. http://dx.doi.org/10.1007/bf00563307.

Full text

APA, Harvard, Vancouver, ISO, and other styles

36

Popov, S. V., I. N. Orlov, D. Yu Chernysheva, T. M. Topuzov, S. M. Malevich, and V. A. Neradovskiy. "Options for antibacterial prophylaxis of infectious complications of prostate biopsy." Experimental and Сlinical Urology 14, no. 3 (2021): 150–55. http://dx.doi.org/10.29188/2222-8543-2021-14-3-150-155.

Full text

Abstract:

Introduction. Amount of prostate biopsy procedures rises every year and up to 95% of cases of prostate biopsy is performed via transrectal approach. The incidence of infectious complications of transrectal prostate biopsy reaches up to 17%, while incidence of such complications of transperineal biopsy is about 1%. The majority of international clinical guidelines recommends for obligatory antibiotic prophylaxis prior to prostate biopsy of any approach, but the choice of antibiotic is still debatable. The aim of this review is to sum up the approaches of international urological guidelines to t

APA, Harvard, Vancouver, ISO, and other styles

37

Shaikh, Quratulain, Samreen Sarfaraz, Anum Rahim, et al. "WHO Point Prevalence Survey to Describe the Use of Antimicrobials at a Tertiary Care Center in Pakistan: A Situation Analysis for Establishing an Antimicrobial Stewardship Program." Antibiotics 11, no. 11 (2022): 1555. http://dx.doi.org/10.3390/antibiotics11111555.

Full text

Abstract:

Antimicrobial stewardship is a systematic approach for promoting and monitoring responsible antimicrobial use globally. We conducted a prospective point prevalence survey of antimicrobial utilization among hospitalized adult patients during September 2021. The survey instrument was adapted from the WHO methodology for point prevalence surveys, and it was conducted at The Indus Hospital and Health Network, Karachi. Among the 300 admitted patients, 55% were males and the mean age was 44 (±18) years. At least 67% of the patients received one antimicrobial agent and the most common indication was

APA, Harvard, Vancouver, ISO, and other styles

38

Grose, Kyle, Karen K. Ballen, Tamila L. Kindwall-Keller, et al. "Ciprofloxacin Prophylaxis Does Not Affect Incidence of Clostridium Difficile Infection in Autologous Stem Cell Transplant Patients." Blood 132, Supplement 1 (2018): 3435. http://dx.doi.org/10.1182/blood-2018-99-111990.

Full text

Abstract:

Abstract Introduction Clostridium difficile infection (CDI) is a major cause of morbidity and mortality in hospitalized patients. In autologous stem cell transplant (ASCT) recipients the national estimated incidence is approximately 5% to 10%. The use of antibacterial agents, such as ciprofloxacin, which historically has been used as a prophylactic agent in our autologous stem cell transplant population, is considered to be a risk factor for developing CDI. However, there have been few studies that have investigated the relationship of prophylactic antibiotics in the ASCT population and the de

APA, Harvard, Vancouver, ISO, and other styles

39

Alkatheri, Abdulmalik M., Abdulkareem M. Albekairy, Shemylan Alharbi, et al. "Investigation of the effectiveness of antibacterial prophylaxis in renal transplant recipients." Journal of Infection in Developing Countries 8, no. 10 (2014): 1244–51. http://dx.doi.org/10.3855/jidc.5202.

Full text

Abstract:

Introduction: Bacterial urinary tract infections (UTIs) are very common complications in renal transplant recipients (RTRs). Methodology: This study is a follow-up to a previous investigation of post-renal transplant UTIs, which led to changes in the antibacterial agents used for prophylaxis and its duration. In this retrospective study of the medical records of 86 RTRs, the incidence, risk factors, causative bacteria, and duration prophylaxis were investigated. Results: The average age of the RTRs was 41.55 ± 14.06 years, and two-thirds of them were males. A total of 57.3% of the RTRs receive

APA, Harvard, Vancouver, ISO, and other styles

40

&NA;. "Is antibacterial prophylaxis prior to litholapaxy cost effective?" Inpharma Weekly &NA;, no. 1094 (1997): 7. http://dx.doi.org/10.2165/00128413-199710940-00010.

Full text

APA, Harvard, Vancouver, ISO, and other styles

41

M Aghayev, Rauf, Fariz H. Jamalov, Idris T. Achundov, Shahin G. Huseynov, and Tarana P. Jamalova. "Antibacterial Prophylaxis in Emergency Surgery of Abdominal Infection." Euroasian Journal of Hepato-Gastroenterology 8, no. 2 (2018): 116–20. http://dx.doi.org/10.5005/jp-journals-10018-1276.

Full text

APA, Harvard, Vancouver, ISO, and other styles

42

Bollgren, I. "Antibacterial prophylaxis in children with urinary tract infection." Acta Paediatrica 88 (January 2, 2007): 48–52. http://dx.doi.org/10.1111/j.1651-2227.1999.tb01318.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

43

&NA;. "Guidelines for perioperative antibacterial prophylaxis improve prescribing patterns." Inpharma Weekly &NA;, no. 782 (1991): 7. http://dx.doi.org/10.2165/00128413-199107820-00016.

Full text

APA, Harvard, Vancouver, ISO, and other styles

44

&NA;. "The AHA recommends reducing antibacterial prophylaxis against endocarditis." Inpharma Weekly &NA;, no. 787 (1991): 4. http://dx.doi.org/10.2165/00128413-199107870-00011.

Full text

APA, Harvard, Vancouver, ISO, and other styles

45

&NA;. "Antibacterial prophylaxis reduces RTIs in mechanically ventilated patients." Inpharma Weekly &NA;, no. 808 (1991): 18. http://dx.doi.org/10.2165/00128413-199108080-00047.

Full text

APA, Harvard, Vancouver, ISO, and other styles

46

Slavin, M. A., S. Lingaratnam, L. Mileshkin, et al. "Use of antibacterial prophylaxis for patients with neutropenia." Internal Medicine Journal 41, no. 1b (2011): 102–9. http://dx.doi.org/10.1111/j.1445-5994.2010.02341.x.

Full text

APA, Harvard, Vancouver, ISO, and other styles

47

Madsen, P. O. "Editorial: Antibacterial Therapy and Prophylaxis in Transurethral Surgery." Journal of Urology 138, no. 1 (1987): 228. http://dx.doi.org/10.1016/s0022-5347(17)43079-5.

Full text

APA, Harvard, Vancouver, ISO, and other styles

48

Vreugdenhil, Gerard, Theo De Witte, and BenE De Pauw. "Treatment of febrile neutropenic patients receiving antibacterial prophylaxis." Lancet 340, no. 8819 (1992): 618–19. http://dx.doi.org/10.1016/0140-6736(92)92160-h.

Full text

APA, Harvard, Vancouver, ISO, and other styles

49

Madsen, P. O. "Editorial: Antibacterial therapy and prophylaxis in transurethral surgery." Urological Research 14, no. 4 (1986): 177–78. http://dx.doi.org/10.1007/bf00441108.

Full text

APA, Harvard, Vancouver, ISO, and other styles

50

Jikia, D., T. Chkhikvadze, I. Mgaloblishvili та K. Gzobava. "ანტიბიოტიკები: რაციონალური გამოყენების პრინციპები (ქირურგიული ანტიბიოტიკოპროფილაქტიკის საკითხები)". Guram Tatishvili Bulletin of Georgia Surgery, № 09 (25 грудня 2021): 36–43. http://dx.doi.org/10.48412/gtbgs.2021.09.36-43.

Full text

Abstract:

The article discusses the key issues and definitions of antibacterial therapy. The main properties and mechanisms of action of antibiotics are described. Attention is drawn to the postulates of the use of antibiotics in clinical practice and the principles of modern rational antibacterial therapy. In the form of tables, the main approaches to surgical "antibacterial therapy" in the pre- and postoperative period, in different areas of surgery, are presented separately. ნაშრომში განხილულია ანტიბიოტიკოთერაპიის საკვანძო საკითხები და დეფინიციები. აღწერილია ანტიბიოტიკების ძირითადი თვისებები და მოქმე

APA, Harvard, Vancouver, ISO, and other styles

We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!